- Report
- March 2024
- 194 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- January 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- May 2024
- 139 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,219GBP
- Report
- February 2021
- 500 Pages
United States
From €1945EUR$2,040USD£1,658GBP
€2288EUR$2,400USD£1,950GBP
- Report
- February 2024
- 70 Pages
India
From €4528EUR$4,750USD£3,860GBP
- Report
- November 2020
- 225 Pages
Global
From €10482EUR$10,995USD£8,934GBP
- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more